Lantheus Medical Imaging, Inc.
company.status.inactiveCIK 1500157fmd_1K703E662XC10WHP1BBV46N9DPManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2015, 21 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|
| Total revenues | 360 | 354 | 356 | 288 | 284 | 302 |
| Cost of revenue | 185 | 204 | 261 | 213 | 206 | 176 |
| Gross profit | 175 | 150 | 95 | 75 | 77 | 126 |
| Research and development | 45 | 45 | 41 | 41 | 30 | 14 |
| Selling, general and administrative | 78 | 75 | 71 | 70 | 68 | 70 |
| Total operating expenses | 122 | 121 | 112 | 76 | 96 | 84 |
| Operating income | 53 | 29 | (16) | (1) | (19) | 42 |
| Interest expense | 13 | 20 | 38 | 42 | 43 | 42 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 3 | 1 | 1 | (0) | 1 | 0 |
| Income before taxes | 42 | 7 | (52) | (43) | (61) | 0 |
| Income tax expense | 22 | 2 | 84 | (1) | 1 | 1 |
| Net income from continuing operations | 20 | 5 | (136) | (42) | (62) | (1) |
| Net income | – | 5 | – | – | – | – |
| Net income to common shareholders | 20 | 5 | (136) | (42) | (62) | (1) |